Published in Neuroscience on January 01, 2002
Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci U S A (2003) 5.25
Forebrain pain mechanisms. Brain Res Rev (2008) 1.89
Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci (2008) 1.48
The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci U S A (2005) 1.34
Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain (2007) 1.21
The dark side of food addiction. Physiol Behav (2011) 1.12
Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology (2009) 1.08
The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res (2009) 1.06
Amygdala pain mechanisms. Handb Exp Pharmacol (2015) 1.06
Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism. Neuropharmacology (2011) 1.05
Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression. J Clin Invest (2013) 0.97
Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses. Mol Pain (2013) 0.96
Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers. Exp Neurol (2011) 0.95
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal. Psychopharmacology (Berl) (2005) 0.93
CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food. Neuropsychopharmacology (2013) 0.89
Predator odor stress alters corticotropin-releasing factor-1 receptor (CRF1R)-dependent behaviors in rats. Neuropharmacology (2013) 0.86
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology (Berl) (2007) 0.84
Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA). Neuropharmacology (2013) 0.81
Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure. Neuroscience (2009) 0.81
The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam Horm (2010) 0.81
Increased motivation to eat in opiate-withdrawn mice. Psychopharmacology (Berl) (2011) 0.80
Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain. Alcohol Alcohol (2014) 0.79
Knockdown of corticotropin-releasing factor in the central amygdala reverses persistent viscerosomatic hyperalgesia. Transl Psychiatry (2015) 0.79
Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia. Addict Biol (2013) 0.78
The affective dimension of pain as a risk factor for drug and alcohol addiction. Alcohol (2015) 0.77
Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor. Synapse (2011) 0.76
Substance use modulates stress reactivity: Behavioral and physiological outcomes. Physiol Behav (2016) 0.76
Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice. Stress (2010) 0.75
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci (1995) 3.00
Anatomy of CNS opioid receptors. Trends Neurosci (1988) 2.82
Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience (1995) 2.69
Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (1991) 2.63
Endogenous opioids: biology and function. Annu Rev Neurosci (1984) 2.54
Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci (1987) 2.53
Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci (2000) 2.42
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science (1976) 2.35
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol (1994) 2.33
Controlling signaling with a specifically designed Gi-coupled receptor. Proc Natl Acad Sci U S A (1998) 2.22
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Analgesia from electrical stimulation in the brainstem of the rat. Science (1971) 1.81
Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci (1999) 1.80
Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol (1999) 1.76
Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry (1991) 1.75
Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron (1993) 1.68
Social stress in hamsters: defeat activates specific neurocircuits within the brain. J Neurosci (1997) 1.60
Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat (1995) 1.56
Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci (1990) 1.56
Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology (1997) 1.55
Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol (1999) 1.52
Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci (1989) 1.50
Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. Eur J Pharmacol (1999) 1.48
Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A (1993) 1.47
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
A food predictive cue must be attributed with incentive salience for it to induce c-fos mRNA expression in cortico-striatal-thalamic brain regions. Neuroscience (2011) 1.41
Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther (1996) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol (1989) 1.38
Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat (1997) 1.37
Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav (2000) 1.34
mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res (1994) 1.34
Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop. Eur J Pharmacol (2000) 1.32
Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology (Berl) (2001) 1.32
Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci (1998) 1.31
Differential expression of c-fos mRNA within neurocircuits of male hamsters exposed to acute or chronic defeat. J Neuroendocrinol (1999) 1.31
Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res (1999) 1.31
Pain reduction by electrical brain stimulation in man. Part 2: Chronic self-administration in the periventricular gray matter. J Neurosurg (1977) 1.30
Nonopiate effects of dynorphin and des-Tyr-dynorphin. Science (1982) 1.29
Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res (1995) 1.29
Immunocytochemical localization of methionine enkephalin: preliminary observations. Life Sci (1977) 1.28
Evidence for two separate opiate peptide neuronal systems. Nature (1978) 1.28
The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res (1995) 1.24
Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinol (1995) 1.23
Neural circuits mediating stress. Biol Psychiatry (1999) 1.22
Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies. Proc Natl Acad Sci U S A (1981) 1.19
Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. J Pharmacol Exp Ther (1998) 1.19
Localization of the 90-kDa heat shock protein-binding site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J Biol Chem (1991) 1.19
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience (1997) 1.18
Detection of proopiomelanocortin mRNA by in situ hybridization with an oligonucleotide probe. Proc Natl Acad Sci U S A (1986) 1.16
Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry (1994) 1.16
Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol Cell Neurosci (1994) 1.15
Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. Br J Psychiatry (1991) 1.14
Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci (2001) 1.13
Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res (1992) 1.13
Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature (1977) 1.13
The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res (1996) 1.12
Monoaminergic mechanisms of stimulation-produced analgesia. Brain Res (1975) 1.12
A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience (1992) 1.11
Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science (1982) 1.11
Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J Chem Neuroanat (2001) 1.11
DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis (2003) 1.10
Key residues defining the mu-opioid receptor binding pocket: a site-directed mutagenesis study. J Neurochem (1997) 1.10
Pain reduction by electrical brain stimulation in man. Part 1: Acute administration in periaqueductal and periventricular sites. J Neurosurg (1977) 1.10
Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain. Brain Res Mol Brain Res (1997) 1.09
Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res (2001) 1.08
Site-directed mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol (1992) 1.08
Dynorphin and vasopressin: common localization in magnocellular neurons. Science (1982) 1.08
Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience (2003) 1.07
A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains. J Biol Chem (1995) 1.06
Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter. Genes Brain Behav (2007) 1.05
Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol Pharmacol (2000) 1.05
Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress. Neuroendocrinology (2005) 1.05
The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences. Neuropharmacology (2004) 1.05
Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior. Neuroscience (2007) 1.05
Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. Mol Pharmacol (1998) 1.05
Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res (1996) 1.04
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. J Pharmacol Exp Ther (1999) 1.04
Expression of alpha(1b) adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci (1999) 1.02
Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology (1991) 1.02
The effect of stressor controllability on stress-induced neuropeptide mRNA expression within the paraventricular nucleus of the hypothalamus. J Neuroendocrinol (1999) 1.01
Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test. Psychopharmacology (Berl) (2008) 1.01
Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res (1994) 1.01
Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology (1996) 1.01
Lesions of the medial geniculate nuclei specifically block corticosterone release and induction of c-fos mRNA in the forebrain associated with audiogenic stress in rats. J Neurosci (1997) 1.00
Dynorphin immunocytochemistry in the rat central nervous system. Peptides (1983) 1.00
Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci (1993) 1.00
Direct evidence of nitric oxide presence within mitochondria. Biochem Biophys Res Commun (2000) 1.00
Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience (1996) 1.00
The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience (1997) 0.99
Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. Proc Natl Acad Sci U S A (1994) 0.99
Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor. Brain Res (1972) 0.98
Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology (2000) 0.98
The degradation of dynorphin A in brain tissue in vivo and in vitro. Peptides (1987) 0.98
Individual differences in novelty-seeking behavior in rats: a c-fos study. Neuroscience (2001) 0.97
Stress during adolescence alters behavioral sensitization to amphetamine. Neuroscience (2002) 0.97
Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J Pharmacol Exp Ther (1997) 0.97